Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function

US10022353B2 · kind B2 · utility

Assignee

• GRÜNENTHAL GMBH · DE

Inventors

• Elke Kleideiter · Aachen, DE
• Annette Christoph · Aachen, DE
• Rene Fussen · Würselen, DE
• Joachim Ossig · Stolberg, DE
• Ramesh Boinpally · Broomfield, US

Key dates

• Filing date: Jan 22, 2016
• Grant date: Jul 17, 2018
• Expiry date: Jan 22, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P29/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to Cebranopadol or a physiologically acceptable salt thereof for use in the treatment or the prevention of pain and/or opioid drug dependence in a subject with impaired hepatic and/or renal function.